Schwartz Aharon 4
4 · Protalix BioTherapeutics, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Schwartz Aharon
Director
Transactions
- Purchase
Common Stock
2023-01-03$1.42/sh+110,000$155,815→ 174,000 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $1.430 to $1.405 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.